American Journal of Preventive Cardiology
metrics 2024
Leading the Charge in Preventive Cardiology Insights.
Introduction
American Journal of Preventive Cardiology, published by ELSEVIER, is a premier Open Access journal that has been making significant strides in the field of cardiology since its inception in 2020. With an impressive impact factor and recognized as a Q1 journal in the Cardiology and Cardiovascular Medicine category as of 2023, it ranks 77th out of 387 in the Scopus database, placing it in the 80th percentile of its field. The journal aims to promote the latest research and practices in preventive cardiology, addressing the global burden of cardiovascular diseases through a combination of innovative findings and practical applications. With the advantage of Open Access, all published articles are readily available to researchers, professionals, and students worldwide, fostering a broad dissemination of knowledge and encouraging collaboration across disciplines. Based in Amsterdam, Netherlands, the journal is committed to advancing the science and prevention of heart disease, making it an essential resource for those dedicated to improving cardiovascular health.
Metrics 2024
Metrics History
Rank 2024
Scopus
IF (Web Of Science)
JCI (Web Of Science)
Quartile History
Similar Journals
Clinica e Investigacion en Arteriosclerosis
Pioneering research that shapes the future of cardiology.Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.
Cardiovascular Diagnosis and Therapy
Advancing Cardiovascular Care Through Innovative ResearchCardiovascular Diagnosis and Therapy, an esteemed journal in the field of Cardiology and Cardiovascular Medicine, is published by AME PUBLISHING COMPANY, based in Hong Kong, China. With an ISSN of 2223-3652 and an E-ISSN of 2223-3660, this open-access journal aims to present cutting-edge research that significantly advances diagnostic and therapeutic practices in cardiovascular health. Recognized for its impact, it holds a 2023 category quartile ranking of Q2 and is positioned at rank #124 out of 387 in Scopus, reflecting its noteworthy contribution to medical literature with a percentile of 68th. The journal welcomes contributions that span various aspects of cardiovascular research, including clinical trials, epidemiological studies, and innovative therapeutic approaches, making it a vital resource for researchers, practitioners, and students alike, committed to improving cardiovascular care.
Cardiology Research
Advancing cardiovascular science for a healthier tomorrow.Cardiology Research is a prominent open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine, published by ELMER PRESS INC. Renowned for its rigorous peer-review process, the journal provides a platform for cutting-edge research and innovative clinical practices in cardiology. With an ISSN of 1923-2829 and an E-ISSN of 1923-2837, it has established an impactful presence in the academic community, achieving a 2023 Scopus quartile ranking of Q3 in its category, positioning it in the 41st percentile. The journal's scope encompasses various aspects of cardiology research, including but not limited to epidemiology, diagnostics, therapeutics, and cardiovascular interventions. Although it operates without open access in certain contexts, it provides flexible access options for readers, ensuring that its valuable insights are widely disseminated. Cardiology Research is an essential resource for researchers, healthcare professionals, and students who aspire to stay at the forefront of cardiovascular science, contributing significantly to the global discourse on heart health.
Indian Heart Journal
Empowering Research to Transform Cardiac CareIndian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.
HEART
Exploring New Frontiers in Heart HealthHEART is a leading peer-reviewed journal published by the BMJ Publishing Group, specializing in the field of Cardiology and Cardiovascular Medicine. Established in 1942, the journal has evolved as a premier platform for disseminating high-quality research, innovative practices, and clinical advancements within the cardiovascular domain. With an impressive impact factor and ranked in the Q1 category in 2023, it positions itself among the top-tier journals in its field, boasting a Scopus rank of #37 out of 387 in this highly competitive area, representing the top 10th percentile nationally. The journal supports both traditional and open access options, thereby enhancing the global visibility and reach of its published work. Researchers, professionals, and students alike will find HEART to be an invaluable resource, offering the latest insights and developments that drive the field forward and improve patient care worldwide.
CIRCULATION
Shaping the Future of Cardiology Through Rigorous Research.CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.
Netherlands Heart Journal
Leading the Way in Cardiovascular Research and PracticeNetherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.
Research in Cardiovascular Medicine
Exploring innovative solutions in cardiovascular health.Research in Cardiovascular Medicine is a renowned open-access journal published by Wolters Kluwer Medknow Publications, dedicated to advancing knowledge in the swiftly evolving field of cardiovascular health. With an ISSN of 2251-9572 and E-ISSN of 2251-9580, this journal serves as a vital platform for researchers and professionals to share their findings, explore innovative treatments, and discuss current trends in cardiovascular care. Since transitioning to open access in 2013, it has democratized access to high-quality research, ensuring that vital information reaches healthcare practitioners and academia alike. The journal’s commitment to rigorous peer review and its emphasis on cutting-edge research contribute significantly to improving patient outcomes and addressing the global burden of cardiovascular diseases. By publishing original articles, review papers, and clinical studies, Research in Cardiovascular Medicine plays a crucial role in shaping the future of cardiovascular research and education, appealing to a wide audience of researchers, professionals, and students striving to make meaningful contributions to this critical field.
Nature Reviews Cardiology
Unveiling Insights that Shape Cardiac CareNature Reviews Cardiology, published by NATURE PORTFOLIO, stands as a premier academic journal in the field of cardiology and cardiovascular medicine, boasting an impressive impact factor and a distinguished ranking of #1 out of 387 in Scopus. Since its inception in 2009, this exemplary journal has continuously delivered cutting-edge reviews and insights, supporting researchers, healthcare professionals, and students in navigating the complex landscape of cardiovascular health. With a commitment to providing open access and disseminating rigorous research, Nature Reviews Cardiology captures the forefront of innovation and scholarship, critical for facilitating advancements in cardiovascular science and clinical practice. Situated in the United Kingdom and with a vibrant global readership, this journal perpetuates academic excellence, ensuring accessibility to the latest findings that shape prevention, diagnosis, and treatment strategies in cardiology through to 2024 and beyond.
International Heart Journal
Advancing Cardiovascular Knowledge GloballyInternational Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.